| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.5 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.019 | 0.5 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.5 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | 0.02 | 0.5 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.047 | 0.6 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | 0.03 | 0.6 |